Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.
J Med Chem
; 62(17): 7769-7787, 2019 09 12.
Article
in En
| MEDLINE
| ID: mdl-31415176
Full text:
1
Database:
MEDLINE
Main subject:
Pyrazines
/
Asthma
/
Anti-Asthmatic Agents
/
Enzyme Inhibitors
/
Drug Discovery
/
Glutathione Transferase
Type of study:
Prognostic_studies
Language:
En
Journal:
J Med Chem
Year:
2019
Type:
Article